Managers / Q1 2020 · view latest →
Boussard & Gavaudan Investment Management LLP
CIK 0001614986 · 70 PALL MALL, London, SW1Y 5ES · 00-44-203-751-5400
Reported Value
$461M
Q1 2020
Positions
29
Filings on Record
33
2019–present window
Filed
May 27, 2020
original filing
Summary
Boussard & Gavaudan Investment Management Llp reported $461M in U.S.-listed holdings across 29 positions for Q1 2020.
The portfolio is heavily concentrated: Allergan alone accounts for 44.3% of reported value.
Compared with Q4 2019, the fund opened 20 new positions and exited 13.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Other · 72.3% · $333M
- Common Stock · 26.1% · $121M
- Unit · 1.2% · $6M
- Right · 0.3% · $2M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.1B | 99 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.3B | 99 | Feb 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $809M | 81 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $779M | 61 | Aug 19, 2025 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2025 | $637M | 58 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.2B | 92 | Feb 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.1B | 79 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $628M | 81 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $695M | 95 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $514M | 91 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $856M | 117 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.1B | 123 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.1B | 124 | May 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $903.4B | 136 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $705M | 154 | Nov 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $551M | 135 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $762M | 66 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.1B | 145 | Feb 15, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2021 | $1.2B | 139 | Nov 9, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2021 | $1.1B | 110 | Aug 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.0B | 93 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $702M | 69 | Feb 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $776M | 58 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $527M | 42 | Jul 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $461M | 29 | May 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $449M | 22 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $746M | 27 | Nov 22, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $650M | 25 | Jul 24, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $3.0B | 21 | May 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $2.1B | 19 | Jan 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.